10-12-2025, 17:35

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Notified -
Globe Newswire10-12-2025, 17:35
22-10-2025, 17:12

JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

Notified -
Globe Newswire22-10-2025, 17:12